INS and COVID-19: In critically ill COVID‐19 patients specifically, both a decreased time in a normoglycaemic range and increased insulin requirements in comparison to non‐COVID‐19 patients have been reported; this has been associated with an increase in ventilator use and mortality among these patients.11